Mmcap International Inc. Spc Biom X Inc. Transaction History

Mmcap International Inc. Spc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.26 - $0.61 $108,081 - $253,575	-415,697 Reduced 81.11%	96,805 $27,000
Q3 2023 Nov 13, 2023	SELL	$0.34 - $0.47 $44,861 - $62,015	-131,947 Reduced 20.47%	512,502 $179,000
Q2 2023 Aug 14, 2023	BUY	$0.25 - $0.42 $9,071 - $15,240	36,287 Added 5.97%	644,449 $232,000
Q1 2023 May 11, 2023	SELL	$0.18 - $0.57 $13,732 - $43,484	-76,289 Reduced 11.15%	608,162 $182,000
Q2 2020 Aug 14, 2020	SELL	N/A	-54,319 Reduced 7.35%	684,451 $3.78 Million

Q1 2020 May 14, 2020	BUY	N/A	738,770 New	738,770 $5.17 Million

13.8M

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $9.89M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Mmcap International Inc. Spc, based on Form 13F filings with the SEC.

Stay updated on Mmcap International Inc. Spc with notifications on news.